Saboui Myriam, Squires Susan G
Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.
Can Commun Dis Rep. 2020 Nov 5;46(11-12):427-431. doi: 10.14745/ccdr.v46i1112a10.
An increase in mumps incidence was observed in late 2016 (365 cases in 2016 compared to 59 cases in 2015). This unusual level of mumps activity prompted the Public Health Network Council and the National Advisory Committee on Immunization to request situation awareness updates from the Centre for Immunization and Respiratory Infectious Diseases (CIRID) at the Public Health Agency of Canada in 2017 and 2018.
A mumps outbreak survey was developed and administered by epidemiologists within CIRID and sent electronically to provincial and territorial public health officials in charge of mumps surveillance. The survey collected information on mumps outbreaks pertaining to demographics, risk factors, laboratory data and public health interventions. The first survey collected data on outbreaks occurring between January 1, 2016 and February 28, 2017, while the second survey contained outbreak data from January 1, 2017 to July 31, 2018. Duplicate outbreaks entries were removed.
The response rate for the first and second surveys was 61% and 69%, respectively. Twenty-four mumps outbreaks across nine provinces were reported between January 1, 2016 and July 31, 2018, for a cumulative total of 881 mumps cases. Adolescents and adults 15 to 39 years of age accounted for the majority of cases (80.6%). Specifically, adults 20 to 24 years of age represented the largest proportion of cases (24.6%). Community and social gatherings were the most common exposure setting (62.5%). Slightly more than one third of cases were known to have received at least two doses of mumps-containing vaccine (35.6%).
Results from the surveys indicate that the increase in mumps activity was widespread throughout Canada, affecting multiple jurisdictions. Young adults accounted for the largest proportion of cases. These surveys provided evidence to support recommendations on the use of additional mumps vaccination in outbreak settings.
2016年末观察到腮腺炎发病率上升(2016年有365例,而2015年为59例)。这种异常的腮腺炎活动水平促使公共卫生网络委员会和国家免疫咨询委员会在2017年和2018年要求加拿大公共卫生局免疫与呼吸道传染病中心(CIRID)提供疫情态势更新。
CIRID的流行病学家制定并实施了一项腮腺炎疫情调查,并以电子方式发送给负责腮腺炎监测的省级和地区公共卫生官员。该调查收集了与人口统计学、风险因素、实验室数据和公共卫生干预措施相关的腮腺炎疫情信息。第一次调查收集了2016年1月1日至2017年2月28日期间发生的疫情数据,而第二次调查包含了2017年1月1日至2018年7月31日的疫情数据。重复的疫情记录被剔除。
第一次和第二次调查的回复率分别为61%和69%。2016年1月1日至2018年7月31日期间,九个省份报告了24起腮腺炎疫情,累计共881例腮腺炎病例。15至39岁的青少年和成年人占病例的大多数(80.6%)。具体而言,20至24岁的成年人占病例的比例最大(24.6%)。社区和社交聚会是最常见的暴露场所(62.5%)。已知略多于三分之一的病例至少接种了两剂含腮腺炎疫苗(35.6%)。
调查结果表明,腮腺炎活动的增加在加拿大各地普遍存在,影响了多个司法管辖区。年轻成年人占病例的比例最大。这些调查为支持在疫情环境中使用额外腮腺炎疫苗接种的建议提供了证据。